This paper is in the following e-collection/theme issue:

Non-Randomized Study Protocols and Methods (Non-eHealth) (571)

Published on in Vol 7, No 10 (2018): October

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/11218, first published .
The Clinical and Cost-Effectiveness of 4 Enzyme-Linked Immunosorbent Assay Kits for Monitoring Infliximab in Crohn Disease Patients: Protocol for a Validation Study

The Clinical and Cost-Effectiveness of 4 Enzyme-Linked Immunosorbent Assay Kits for Monitoring Infliximab in Crohn Disease Patients: Protocol for a Validation Study

The Clinical and Cost-Effectiveness of 4 Enzyme-Linked Immunosorbent Assay Kits for Monitoring Infliximab in Crohn Disease Patients: Protocol for a Validation Study

Authors of this article:

Thomas Langford1 Author Orcid Image ;   Zehra Arkir2 Author Orcid Image ;   Anastasia Chalkidou1 Author Orcid Image ;   Kate Goddard1 Author Orcid Image ;   Lamprini Kaftantzi1 Author Orcid Image ;   Mark Samaan3 Author Orcid Image ;   Peter Irving3 Author Orcid Image
Article Authors Cited by (2) Tweetations (3) Metrics

Thomas Langford   1 , MSc ;   Zehra Arkir   2 , FRCPath ;   Anastasia Chalkidou   1 , MBBS, PhD ;   Kate Goddard   1 , PhD ;   Lamprini Kaftantzi   1 , PhD ;   Mark Samaan   3 , MBBS, BSc ;   Peter Irving   3 , MA MD FRCP

1 King's Technology Evaluation Centre, School of Biomedical Engineering and Imaging Sciences, King's College London, London, United Kingdom

2 Reference Chemistry Laboratory, Viapath, St Thomas' Hospital, London, United Kingdom

3 Department of Gastroenterology, Guy's & St Thomas' National Health Service Trust, London, United Kingdom

Corresponding Author:

  • Anastasia Chalkidou, MBBS, PhD
  • King's Technology Evaluation Centre
  • School of Biomedical Engineering and Imaging Sciences
  • King's College London
  • 5th Floor, Becket House
  • 1 Lambeth Palace Road
  • London, SE1 7EU
  • United Kingdom
  • Phone: 44 20 784 89527
  • Email: anastasia.chalkidou@kcl.ac.uk